Cite
HARVARD Citation
Ominsky, M. et al. (2013). THU0397 Increased Bone Mass and Bone Strength by Sclerostin Antibody (Scl-Ab) is Maintained by a RANKL Inhibitor in OVX Rats with Established Osteopenia. Annals of the rheumatic diseases. pp. A299-A300. [Online].